Japan Medical Dynamic Marketing (7600) FY2026 Q3 Earnings Report

Quick View

Executive Summary

This was a decline in both revenue and earnings, with earnings deteriorating more sharply than revenue, as reduced capacity to absorb SG&A expenses pressured profitability. Revenue was ¥179.3B (down -2.9% YoY), Operating Income was ¥5.2B (down -57.9%), Ordinary Income was ¥4.8B (down -60.2%), and Net Income was ¥3.0B (compared with ¥9.0B in the previous year). Although the gross profit margin remained high at 60.1%, SG&A expenses accounted for 95.2% of gross profit, causing the Operating Income margin to decline to 2.9%.

Factors Affecting Financial Performance

【Revenue】Revenue was ¥179.3B, down 2.9% YoY. By segment, Japan generated ¥98.0B (profit margin: 4.8%), while America generated ¥118.5B (profit margin: 0.7%), with the low profitability of the America Business pulling down the overall profit margin. Although the decline in revenue itself was modest, the contraction in the top line reduced the ability to absorb fixed costs.

【Profit and Loss】Operating Income was ¥5.2B (down -57.9% YoY), Ordinary Income was ¥4.8B (down -60.2%), and Net Income was ¥3.0B (compared with ¥9.0B in the previous year), representing declines in earnings that significantly exceeded the decline in revenue. SG&A expenses of ¥102.5B accounted for 95.2% of gross profit of ¥107.7B, while fixed costs such as salaries and allowances of ¥31.7B and R&D expenses of ¥6.7B were not sufficiently absorbed during the period of declining revenue. In non-operating items, foreign exchange gains of ¥1.5B were almost offset by interest expenses of ¥1.5B, leaving Ordinary Income slightly below Operating Income. After deducting extraordinary losses of ¥0.3B (losses on disposal of fixed assets of ¥0.2B), Net Income was ¥3.0B. In conclusion, this was a decline in both revenue and earnings, with negative operating leverage being the primary cause of the deterioration in profit margins.

Segment Analysis

The Japan segment generated Revenue of ¥98.0B and Operating Income of ¥4.7B (profit margin: 4.8%), accounting for the majority of total profit. Although the America segment exceeded it in scale, with Revenue of ¥118.5B, Operating Income was only ¥0.9B (profit margin: 0.7%), indicating markedly low profitability. America accounted for approximately 56.9% of the revenue mix and Japan approximately 43.1%; the low profitability of the larger America Business was the primary factor depressing the consolidated Operating Income margin to 2.9%.

Key Financial Indicators

【Profitability】The Operating Income margin of 2.9%, Ordinary Income margin of 2.6%, and Net Income margin of 1.6% all contracted significantly from the previous year. In contrast to the high gross profit margin of 60.1%, the heavy SG&A burden constrained profitability.【Cash Quality】Finished-goods inventory of ¥137.6B was equivalent to 76.7% of Revenue, and together with accounts receivable of ¥53.2B, indicates a substantial amount of capital tied up in working capital. Although a statement of cash flows is not disclosed, the scale of inventory and accounts receivable suggests room to improve the speed of cash conversion.【Investment Efficiency】ROE was 1.2%, and profit levels were low relative to total assets of ¥344.7B, indicating limited capital efficiency. R&D expenses of ¥6.7B (3.7% of Revenue) represent investment in maintaining product competitiveness, but are a relatively significant burden at the current level of earnings.【Financial Soundness】The Equity Ratio was high at 73.0%, indicating a conservative financial base. Of interest-bearing debt of ¥53.0B, short-term borrowings accounted for ¥44.5B, warranting attention because dependence on short-term funding is somewhat high.

Cash Flow Analysis

Although detailed financial statements of cash flows are not disclosed, cash trends can be inferred from changes in the balance sheet. Cash and deposits stood at ¥24.8B, down from ¥31.8B in the previous year. Meanwhile, finished-goods inventory increased from ¥99.3B in the previous year to ¥137.6B, expanding the amount of funds tied up in working capital. Accounts receivable was ¥53.2B, slightly down from ¥61.3B in the previous year. Short-term borrowings were ¥44.5B, up from ¥31.4B in the previous year, suggesting that funding needs associated with inventory accumulation were being covered through short-term borrowings. Overall, the increase in inventory led to a decline in cash and an increase in borrowings, making improvements in inventory turnover the key to future cash trends.

Earnings Quality

Of Ordinary Income of ¥4.8B, foreign exchange gains of ¥1.5B accounted for the majority of non-operating income and were almost offset by interest expenses of ¥1.5B in non-operating expenses. Consequently, Ordinary Income remained slightly below Operating Income of ¥5.2B, indicating relatively high dependence on foreign exchange, a factor of a non-recurring nature. Extraordinary losses of ¥0.3B resulted from losses on disposal of fixed assets and had a limited impact on Net Income as a temporary factor. Comprehensive Income was ¥8.1B, exceeding Net Income of ¥3.0B, with the difference primarily attributable to foreign currency translation adjustments of ¥5.3B. This divergence reflects accounting fluctuations arising from the translation of overseas subsidiaries into yen and does not directly indicate the earnings power of operating activities themselves.

Earnings Forecast and Guidance

Progress against the full-year company forecast was 72.3% for Revenue, 74.0% for Operating Income, and 86.4% for Ordinary Income. While Revenue and Operating Income were broadly in line with the standard Q3 cumulative progress level (approximately 75%), Ordinary Income was ahead of schedule, suggesting limited room for additional Ordinary Income in the remaining quarter. The full-year forecast is Revenue of ¥248.0B (down -1.3% YoY), Operating Income of ¥7.0B (down -55.0%), and Ordinary Income of ¥5.5B (down -63.1%), indicating that the company plan itself incorporates a significant decline in profitability.

Shareholder Returns

The full-year dividend forecast is ¥17.00 per share, while the Q2 dividend paid was ¥0. Based on forecast full-year EPS of ¥11.38, the Payout Ratio is approximately 149.4%, meaning that the current level of Net Income alone would be insufficient to fund the dividend. Retained earnings of ¥156.4B and net assets of ¥251.5B provide substantial resources for dividends, but dividend sustainability will depend significantly on the recovery of Operating Cash Flow going forward. Data on share buybacks has not been disclosed; accordingly, the assessment here is based on the Payout Ratio and not the Total Return Ratio.

Risk Factors

1. Inventory accumulation risk: Finished-goods inventory was ¥137.6B, equivalent to 76.7% of Revenue, and increased significantly from ¥99.3B in the previous year. If sales momentum stagnates, this could affect the gross profit margin through inventory write-downs and deteriorating pricing conditions.

2. Dependence on short-term borrowings risk: Short-term borrowings of ¥44.5B accounted for 84.0% of interest-bearing debt of ¥53.0B. Although the current ratio is high, sensitivity to changes in refinancing conditions and the interest-rate environment is relatively high.

3. Profitability deterioration risk: While Revenue declined by only 2.9%, Operating Income deteriorated sharply by 57.9%, highlighting reduced capacity to absorb fixed costs such as SG&A and R&D expenses. The low profitability of the America Business (profit margin: 0.7%) is also weighing on profitability.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability metrics are both below the industry median, placing it in the lower range of the industry for both Operating Income margin and Net Income margin.

Growth and Capital Efficiency

The company’s Revenue growth rate is below the industry median, contrasting with the average industry profile of growth in Revenue.

※Source: Compiled by the Company

Key Takeaways from the Results

1. Although the gross profit margin remained high at 60.1%, the Operating Income margin contracted to 2.9%, making the weak ability to absorb SG&A expenses during a period of declining revenue a key focus of the results.

2. The progress rates for full-year Ordinary Income and Net Income were ahead of schedule at 86.4% and 95.7%, respectively, indicating limited room for additional earnings accumulation in the remaining quarter.

3. The increase in finished-goods inventory (up +38.5% YoY) and high dependence on short-term borrowings are structural characteristics evident in the financial results data regarding the extent to which funds are tied up in working capital.

Theoretical Share Price (Reference Value)

Sensitivity: ¥725–¥765 at ±1% for the cost of equity, and ¥739–¥749 at ±0.1 for ω.

Notes:

• Because progress of Net Income against the full-year forecast (96%) exceeds the standard level (75%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies ahead of schedule tend to exceed forecasts. In businesses with strong seasonality, the adjustment may be excessive).
• Net Income is significantly compressed relative to Operating Income due to tax burden, acquisition-related expenses, and non-controlling interests, among other factors (Net Income ÷ Operating Income: 43%). This figure reflects that compression at face value; if the factors are temporary, underlying earnings power may be higher.
• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat on the high side.

(Model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest-rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with professionals as necessary.

---End of Report---